News | July 22, 2023
Glenmark Life Sciences reports robust 25% EBITDA growth in Q1FY24
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
To equip them with the latest knowledge and skills to handle patients coming to them in a better way
First of its kind screening for Glaucoma at grass root level over 10k screened already
Moist wound dressing for chronic wound treatment now available in Germany
The programme was conducted as a part of MPMCx, an exclusive management programme for MBBS doctors by IIM-Ahmedabad in collaboration with DailyRounds
However, PAT growth will be lower than operating profit growth mainly due to brand amortization expenditure on account of acquisition.
The 'A+' rating reflects IOL's robust business model, diversified product portfolio
PEEK brings a new quality to dental care for patients
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
Investment will help fuel international partnerships, grow IGX Platform functionality, and diversify proposition with new generative AI solutions
Subscribe To Our Newsletter & Stay Updated
